{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:52:35Z","timestamp":1768081955823,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.xphs.2023.02.026","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T01:57:59Z","timestamp":1678154279000},"page":"1929-1938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Overcoming the Hydrophobic Nature of Zinc Phenylacetate Through Co-Crystallization with Isonicotinamide"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1354-3453","authenticated-orcid":false,"given":"Soroush","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohrab","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.xphs.2023.02.026_bib0001","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJM198206103062303","article-title":"Treatment of inborn errors of urea synthesis \u2014 activation of alternative pathways of waste nitrogen synthesis and excretion","volume":"306","author":"Batshaw","year":"1982","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.xphs.2023.02.026_bib0002","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17425255.2017.1262843","article-title":"An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease","volume":"13","author":"De Las Heras","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"10.1016\/j.xphs.2023.02.026_bib0003","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1463-1326.2009.01054.x","article-title":"Ammonia toxicity and its prevention in inherited defects of the urea cycle","volume":"11","author":"Walker","year":"2009","journal-title":"Diabetes, Obes Metab"},{"issue":"2","key":"10.1016\/j.xphs.2023.02.026_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1005661631281","article-title":"Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia","volume":"23","author":"Praphanproj","year":"2000","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-publhealth-031210-101209","article-title":"Sodium intake and cardiovascular disease","volume":"32","author":"Morrison","year":"2011","journal-title":"Annu Rev Public Health"},{"issue":"10","key":"10.1016\/j.xphs.2023.02.026_bib0006","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.amjmed.2019.04.040","article-title":"Trends in dietary sodium intake in the united states and the impact of USDA guidelines: NHANES 1999-2016","volume":"132","author":"Brouillard","year":"2019","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1746.2011.06925.x","article-title":"Management of ascites in cirrhosis","volume":"27","author":"Wong","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.xphs.2023.02.026_bib0008","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00204-011-0775-1","article-title":"Zinc and human health: an update","volume":"86","author":"Chasapis","year":"2012","journal-title":"Arch Toxicol"},{"issue":"7","key":"10.1016\/j.xphs.2023.02.026_bib0009","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1080\/00958972.2014.910653","article-title":"Synthesis, characterization, crystal structures, enzyme inhibition, dna binding, and electrochemical studies of zinc(II) complexes","volume":"67","author":"Ali","year":"2014","journal-title":"J Coord Chem"},{"key":"10.1016\/j.xphs.2023.02.026_bib0010","article-title":"Synthesis, structure, and properties of coordination polymers based on 1,4-bis((2-methyl-1H-Imidazol-1-Yl)methyl)benzene and different carboxylate ligands","author":"Liu","year":"2018","journal-title":"Crystals"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0011","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1002\/anie.200700534","article-title":"Crystal engineering: a holistic view","volume":"46","author":"Desiraju","year":"2007","journal-title":"Angew Chemie Int Ed"},{"issue":"10","key":"10.1016\/j.xphs.2023.02.026_bib0012","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1021\/acs.cgd.1c00737","article-title":"Virtual multicomponent crystal screening: hydrogen bonding revisited","volume":"21","author":"Ahmadi","year":"2021","journal-title":"Cryst Growth Des"},{"issue":"24","key":"10.1016\/j.xphs.2023.02.026_bib0013","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1039\/D1CE00337B","article-title":"Desolvation of dasatinib methanolate: an improved anhydrous polymorph","volume":"23","author":"Ahmadi","year":"2021","journal-title":"CrystEngComm"},{"issue":"27","key":"10.1016\/j.xphs.2023.02.026_bib0014","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1021\/ja403264c","article-title":"Crystal engineering: from molecule to crystal","volume":"135","author":"Desiraju","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.xphs.2023.02.026_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.03.003","article-title":"Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design","volume":"117","author":"Berry","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.xphs.2023.02.026_bib0016","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.drudis.2020.11.016","article-title":"Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019","volume":"26","author":"Bharate","year":"2021","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.2600660104","article-title":"Pharmaceutical salts","volume":"66","author":"Berge","year":"1977","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.02.026_bib0018","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4155\/ppa.12.29","article-title":"The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents","volume":"1","author":"Almarsson","year":"2012","journal-title":"Pharm Pat Anal"},{"issue":"17","key":"10.1016\/j.xphs.2023.02.026_bib0019","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1039\/b402150a","article-title":"Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?","author":"Almarsson","year":"2004","journal-title":"Chem Commun"},{"issue":"11","key":"10.1016\/j.xphs.2023.02.026_bib0020","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1021\/acs.cgd.8b01159","article-title":"Salts, cocrystals, and ionic cocrystals of a \u201csimple\u201d tautomeric compound","volume":"18","author":"Wang","year":"2018","journal-title":"Cryst Growth Des"},{"issue":"13","key":"10.1016\/j.xphs.2023.02.026_bib0021","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1021\/acs.chemrev.1c00987","article-title":"Crystal engineering of pharmaceutical cocrystals in the discovery and development of improved drugs","volume":"122","author":"Bolla","year":"2022","journal-title":"Chem Rev"},{"issue":"54","key":"10.1016\/j.xphs.2023.02.026_bib0022","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1039\/C6CC02943D","article-title":"Pharmaceutical cocrystals: walking the talk","volume":"52","author":"Bolla","year":"2016","journal-title":"Chem Commun"},{"issue":"11","key":"10.1016\/j.xphs.2023.02.026_bib0023","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1021\/acs.cgd.5b01293","article-title":"Hydrogen bond synthons in the interplay of solubility and membrane permeability\/diffusion in variable stoichiometry drug cocrystals","volume":"15","author":"Saikia","year":"2015","journal-title":"Cryst Growth Des"},{"issue":"6","key":"10.1016\/j.xphs.2023.02.026_bib0024","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/jps.22434","article-title":"Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics","volume":"100","author":"Cheney","year":"2011","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.02.026_bib0025","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1021\/mp200209j","article-title":"Cocrystals of quercetin with improved solubility and oral bioavailability","volume":"8","author":"Smith","year":"2011","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2023.02.026_bib0026","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1107\/S2052252514004229","article-title":"Acemetacin cocrystals and salts: structure solution from powder X-ray data and form selection of the piperazine salt","volume":"1","author":"Sanphui","year":"2014","journal-title":"IUCrJ"},{"issue":"16","key":"10.1016\/j.xphs.2023.02.026_bib0027","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1039\/C6CE00003G","article-title":"Can we exchange water in a hydrate structure: a case study of etoricoxib","volume":"18","author":"Mittapalli","year":"2016","journal-title":"CrystEngComm"},{"issue":"9","key":"10.1016\/j.xphs.2023.02.026_bib0028","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/cg300784v","article-title":"Pharmaceutical cocrystals of niclosamide","volume":"12","author":"Sanphui","year":"2012","journal-title":"Cryst Growth Des"},{"issue":"8","key":"10.1016\/j.xphs.2023.02.026_bib0029","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/jps.22546","article-title":"Nitrofurantoin\u2013P-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies","volume":"100","author":"Cherukuvada","year":"2011","journal-title":"J Pharm Sci"},{"issue":"38\u201339","key":"10.1016\/j.xphs.2023.02.026_bib0030","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1002\/adma.200900533","article-title":"Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol","volume":"21","author":"Karki","year":"2009","journal-title":"Adv Mater"},{"issue":"2","key":"10.1016\/j.xphs.2023.02.026_bib0031","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1021\/acs.cgd.0c01153","article-title":"Temozolomide\u2013hesperetin drug\u2013drug cocrystal with optimized performance in stability, dissolution, and tabletability","volume":"21","author":"Wang","year":"2021","journal-title":"Cryst Growth Des"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0032","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/D0CE01316A","article-title":"Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation","volume":"23","author":"Mannava","year":"2021","journal-title":"CrystEngComm"},{"issue":"15","key":"10.1016\/j.xphs.2023.02.026_bib0033","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1039\/c3ce26765b","article-title":"Knowledge-based hydrogen bond prediction and the synthesis of salts and cocrystals of the anti-malarial drug pyrimethamine with various drug and GRAS molecules","volume":"15","author":"Delori","year":"2013","journal-title":"CrystEngComm"},{"issue":"5","key":"10.1016\/j.xphs.2023.02.026_bib0034","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1039\/c0sc00555j","article-title":"Virtual cocrystal screening","volume":"2","author":"Musumeci","year":"2011","journal-title":"Chem Sci"},{"issue":"48","key":"10.1016\/j.xphs.2023.02.026_bib0035","doi-asserted-by":"crossref","first-page":"21711","DOI":"10.1002\/anie.202009467","article-title":"Co-crystal prediction by artificial neural networks","volume":"59","author":"Devogelaer","year":"2020","journal-title":"Angew Chemie Int Ed"},{"issue":"21","key":"10.1016\/j.xphs.2023.02.026_bib0036","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1002\/chem.201904672","article-title":"Efficient screening for ternary molecular ionic cocrystals using a complementary mechanosynthesis and computational structure prediction approach","volume":"26","author":"Shunnar","year":"2020","journal-title":"Chem \u2013 A Eur J"},{"issue":"21","key":"10.1016\/j.xphs.2023.02.026_bib0037","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/anie.199523111","article-title":"Supramolecular synthons in crystal engineering\u2014a new organic synthesis","volume":"34","author":"Desiraju","year":"1995","journal-title":"Angew Chemie Int Ed English"},{"issue":"8","key":"10.1016\/j.xphs.2023.02.026_bib0038","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/cg100484a","article-title":"Hierarchy of supramolecular synthons: persistent hydrogen bonds between carboxylates and weakly acidic hydroxyl moieties in cocrystals of zwitterions","volume":"10","author":"Kavuru","year":"2010","journal-title":"Cryst Growth Des"},{"issue":"35","key":"10.1016\/j.xphs.2023.02.026_bib0039","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1039\/C8CE01106K","article-title":"Amine\u2013carboxylate supramolecular synthon in pharmaceutical cocrystals","volume":"20","author":"Li","year":"2018","journal-title":"CrystEngComm"},{"issue":"5","key":"10.1016\/j.xphs.2023.02.026_bib0040","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1039\/c7pp00448f","article-title":"1,2,4,5-Benzenetetracarboxylic acid: a versatile hydrogen bonding template for controlling the regioselective topochemical synthesis of head-to-tail photodimers from stilbazole derivatives","volume":"17","author":"Ortega","year":"2018","journal-title":"Photochem Photobiol Sci"},{"issue":"22","key":"10.1016\/j.xphs.2023.02.026_bib0041","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1039\/c3ce26986h","article-title":"Polymorphism in metformin embonate salt \u2013 recurrence of dimeric and tetrameric guanidinium\u2013carboxylate synthons","volume":"15","author":"Nanubolu","year":"2013","journal-title":"CrystEngComm"},{"key":"10.1016\/j.xphs.2023.02.026_bib0042","series-title":"APEX2, SAINT","year":"2012"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0043","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1107\/S1600576715001132","article-title":"Crystal structure determination and refinement via SIR2014","volume":"48","author":"Burla","year":"2015","journal-title":"J Appl Crystallogr"},{"issue":"2","key":"10.1016\/j.xphs.2023.02.026_bib0044","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J Appl Crystallogr"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr Sect C"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0046","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","article-title":"Mercury 4.0: from visualization to analysis, design and prediction","volume":"53","author":"Macrae","year":"2020","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.xphs.2023.02.026_bib0047","unstructured":"JADE 7.0. Materials Data: Livermore, CA."},{"key":"10.1016\/j.xphs.2023.02.026_bib0048","series-title":"CrystalExplorer17","author":"Turner","year":"2017"},{"key":"10.1016\/j.xphs.2023.02.026_bib0049","series-title":"Gaussian 16, Revision b.01","author":"Frisch","year":"2016"},{"issue":"6","key":"10.1016\/j.xphs.2023.02.026_bib0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0009-2614(88)85250-3","article-title":"MP2 energy evaluation by direct methods","volume":"153","author":"Head-Gordon","year":"1988","journal-title":"Chem Phys Lett"},{"issue":"3","key":"10.1016\/j.xphs.2023.02.026_bib0051","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0009-2614(90)80029-D","article-title":"A Direct MP2 gradient method","volume":"166","author":"Frisch","year":"1990","journal-title":"Chem Phys Lett"},{"key":"10.1016\/j.xphs.2023.02.026_bib0052","doi-asserted-by":"crossref","unstructured":"Gavezzotti, A. Calculation of lattice energies of organic crystals: the PIXEL integration method in comparison with more traditional methods. 2005, 220 (5\u20136), 499\u2013510. doi:10.1524\/zkri.220.5.499.65063.","DOI":"10.1524\/zkri.220.5.499.65063"},{"issue":"2","key":"10.1016\/j.xphs.2023.02.026_bib0053","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.saa.2006.02.050","article-title":"Correlation of infrared spectra of zinc(II) carboxylates with their structures","volume":"66","author":"Zele\u0148\u00e1k","year":"2007","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0054","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-386X(03)00137-3","article-title":"Infrared spectroscopy of metal carboxylates: II. Analysis of Fe(III), Ni and Zn carboxylate solutions","volume":"72","author":"Palacios","year":"2004","journal-title":"Hydrometallurgy"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2014.09.002","article-title":"Influence of surface modification on wettability and surface energy characteristics of pharmaceutical excipient powders","volume":"475","author":"Karde","year":"2014","journal-title":"Int J Pharm"},{"issue":"Supplement_12","key":"10.1016\/j.xphs.2023.02.026_bib0056","doi-asserted-by":"crossref","first-page":"27P","DOI":"10.1111\/j.2042-7158.1985.tb14099.x","article-title":"Assessment of the wettability of pharmaceutical powders using compressed discs","volume":"37","author":"Buckton","year":"1985","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2023.02.026_bib0057","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/jz402762h","article-title":"Definitions for hydrophilicity, hydrophobicity, and superhydrophobicity: getting the basics right","volume":"5","author":"Law","year":"2014","journal-title":"J Phys Chem Lett"},{"issue":"4","key":"10.1016\/j.xphs.2023.02.026_bib0058","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/ed080p447","article-title":"Like dissolves like: a guided inquiry experiment for organic chemistry","volume":"80","author":"Montes","year":"2003","journal-title":"J Chem Educ"},{"issue":"5","key":"10.1016\/j.xphs.2023.02.026_bib0059","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1021\/acs.cgd.0c01673","article-title":"Cocrystallization of amantadine hydrochloride with resveratrol: the first drug\u2013nutraceutical cocrystal displaying synergistic antiviral activity","volume":"21","author":"Wang","year":"2021","journal-title":"Cryst Growth Des"},{"issue":"5","key":"10.1016\/j.xphs.2023.02.026_bib0060","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/acs.molpharmaceut.5b00020","article-title":"Cocrystals of hydrochlorothiazide: solubility and diffusion\/permeability enhancements through drug\u2013coformer interactions","volume":"12","author":"Sanphui","year":"2015","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.02.026_bib0061","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1021\/acsabm.0c01398","article-title":"Enhanced solubility and antitumor activity of curcumin via breaking and rebuilding of the hydrogen bond","volume":"4","author":"Zhu","year":"2021","journal-title":"ACS Appl Bio Mater"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:41:06Z","timestamp":1758361266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0022354923000989"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.02.026","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming the Hydrophobic Nature of Zinc Phenylacetate Through Co-Crystallization with Isonicotinamide","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}